Manufacturer direct-pay program
Both Lilly and Novo Nordisk run self-pay programs for people without coverage. Pricing tiers change frequently — check the official program page for current rates.
How to get GLP-1 covered by insurance
You are trying to work out what this will cost you per month.
Reference and calculator, not medical advice. This page explains how something works; it does not tell you what to take. Last reviewed August 2026.
Most of what determines this happens before anything reaches your insurer, and it is clinical rather than administrative. The indication your prescriber documents, and whether your record supports it, does more than any wording you could put in an appeal.
The sequence that actually matters: establish whether the drug is on your plan's formulary at all, for which indication and at what tier; find out whether prior authorisation applies; and if it does, understand that the criteria are your plan's published clinical requirements rather than a negotiation. Those criteria are usually documented and worth reading before the request goes in.
Where the price comes from
The routes people actually pay through, and what determines the number in each.
Through insurance (copay)
If your plan covers the drug for your indication, your cost is the plan copay. Coverage for weight-loss indications is far less common than for type 2 diabetes.
Telehealth platform (brand drug)
Online clinics bundle a prescriber visit with brand-name medication. Membership fee is usually separate from drug cost.
Compounded semaglutide / tirzepatide
Compounded versions are prepared by pharmacies rather than the original manufacturer. Availability and legality depend on FDA shortage status, which has changed several times — verify current status before relying on this route.
Retail pharmacy cash price
List price without insurance, sometimes reduced by discount cards.
Where a request is denied, plans have a defined appeals process with deadlines, and denials are sometimes overturned when the clinical documentation is completed rather than argued. That is a process your prescriber's office runs far more often than you do, and asking them to handle it is not an imposition.
Common questions
- Is there wording that works?
- No script gets a drug covered that the plan excludes. What changes outcomes is documentation matching the plan’s published criteria, which is why reading those criteria first is the highest-value step.
- Should I try a different drug in the class?
- Formulary position differs between products even with the same active ingredient, so it is a reasonable thing to ask your prescriber about. Which product suits you clinically is their call, not a coverage optimisation.
- How long does prior authorisation take?
- Set by your plan and by state rules, with expedited paths in some circumstances. Your plan documents give the timeframes.
- What if none of this works?
- Self-pay routes exist and are covered elsewhere here. Run whatever quotes you get through the calculator at your maintenance dose rather than your starting dose.
Cost comparison calculator
Enter the quotes you have actually been given. Everything is normalised to cost per month and cost per milligram so the options are comparable.
Monthly requirement21.65 mg4.33 doses/month × 5 mg
| Option | Per month | Per year | Per mg | One unit lasts |
|---|---|---|---|---|
| Option A | — | — | — | — |
| Option B | — | — | — | 2.0 weeks |
Common questions
- Why do quoted GLP-1 prices vary so much?
- Because the quotes are not measuring the same thing. A membership fee, a per-vial price, and a per-pen price all describe different quantities, and the dose you are on determines how long that quantity lasts. Converting everything to cost per milligram is the only way to compare them directly.
- Does insurance usually cover this?
- Coverage is far more common for type 2 diabetes indications than for weight management. Whether your specific plan covers your specific indication is something only your plan documents can answer.
Sources and last review
This page is general reference rather than a dosing table, so it quotes no figures from a label. Nothing here is reviewed by a clinician, and this site does not employ one — which is exactly why what I do publish stays traceable to its source.
- This page carries no product-specific dosing figures. The labels behind everything on this site are listed on the sources page, and the originals live on DailyMed.
Transcribed from the labels above and checked by me — Gavin, who builds this site, takes a GLP-1, and is not a clinician. Last reviewed August 2026. Found an error? [email protected] — I treat corrections as bugs. How this site is built and funded.
Also searched as: glp 1 insurance denial appeal